Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group (Q34064380)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group |
scientific article |
Statements
1 reference
Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group (English)
1 reference
Rhee P
1 reference
Morris J
1 reference
Durham R
1 reference
Hauser C
1 reference
Cipolle M
1 reference
Wilson R
1 reference
Luchette F
1 reference
McSwain N
1 reference
Miller R
1 reference
1 October 2000
1 reference
1 reference
49
1 reference
611-9; discussion 619-20
1 reference
Identifiers
1 reference
1 reference